Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 19/10/2017
SIETES contiene 92082 citas

 
 
 1 a 20 de 345 siguiente >>
Presentar resultados
Seleccionar todas
1. Cita con resumen
Chang S-H, Chou I-J, Yeh Y-H, Chiou M-J, Wen M-S, Kuo C-T, See L-C, Kuo C-F. Association between use of non-vitamin K oral anticoagulants with and without concurrent medications and risk of major bleeding in nonvalvular atrial fibrillation. JAMA 2017;318:1250-9. [Ref.ID 102073]
2. Cita con resumen
Dimmitt S, Stampfer H, Martin JH. When less is more – Efficacy with less toxicity at the ED50. Br J Clin Pharmacol 2017;83:1365-8. [Ref.ID 101984]
3. Cita con resumen
Poudel DR, Acharya P, Ghimire S, Dhital R, Bharati R. Burden of hospitalizations related to adverse drug events in the USA: a retrospective analysis from large inpatient database. Pharmacoepidemiol Drug Saf 2017;26:635-41. [Ref.ID 101626]
4.Tiene citas relacionadas Cita con resumen
Ziff OJ, Lane DA, Samra M, Griffith M, Kirchhof P, Lip GYH, Steeds RP, Townend J, Kotecha D. Safety and efficacy of digoxin: systematic review and meta-analysis of observational and controlled trial data. BMJ 2015;351:h4451. [Ref.ID 99419]
5.Tiene citas relacionadas Cita con resumen
Washam JB, Stevens SR, Lokhnygina Y, Halperin JL, Breidthardt G, Singer DE, Mahaffey KW, Hankey GJ, Berkowtitz SD, Nessel CC, Fox KAA, Califf RM, Piccini JP, Patel MR, ROCKET AF Steering Committee and Investigators. Digoxin use in patients with atrial fibrillation and adverse cardiovascular outcomes: a retrospective analysis of the rivaroxaban once daily oral direct factor Xa inhibition compared with vitamin K antagonism for prevention of stroke and embolism trial in atrial fibrillation (ROCKET AF). Lancet 2015;385:2363-70. [Ref.ID 99291]
6.Tiene citas relacionadas Cita con resumen
Khan SS, Gheorghiade M. Digoxin use in atrial fibrillation: a critical reappraisal. Lancet 2015;385:2330-2. [Ref.ID 99288]
7. Cita con resumen
Vamos M, Erath JW, Hohnloser SH. Digoxin-associated mortality: a systematic review and meta-analysis of the literature . Eur Heart J 2015;36:1831-8. [Ref.ID 99037]
8. Cita con resumen
Warlé-van Herwaarden MF, Valkhoff VE, Herings RMC, Engelkes M, van Blijderveen JC, Rodenburg EM, de Bie S, Alsma J, van de Steeg-Gompel C, Kramers C, Meyboom RHB, Sturkenboom MCJM, De Smet PAGM. Quick assessment of drug-related admissions over time (QUADRAT study). Pharmacoepidemiol Drug Saf 2015;24:495-503. [Ref.ID 98885]
9. Cita con resumen
Anónimo. Patients affected by jump in prices of generic medicines. DIA Daily 2014:9 de julio. [Ref.ID 97745]
10. Cita con resumen
Muneer A, Kalsi J, Nazareth I, Arya M. Erectile dysfunction. BMJ 2014;348:g129. [Ref.ID 97218]
11. Cita con resumen
Schubert I, Küpper-Nybelen J, Ihle P, Thürmann P. Prescribing potentially inappropriate medication (PIM) in Germany's elderly as indicated by the PRISCUS list. An analysis based on regional claims data. Pharmacoepidemiol Drug Saf 2013;22:719-27. [Ref.ID 95806]
12. Cita con resumen
Montastruc J-L. Médicaments et drogues à l'origine de dysfonctions érectiles. Bulletin d'Informations de Pharmacologie 2013;20:2. [Ref.ID 95184]
13. Cita con resumen
14. Cita con resumen
Anónimo. Digoxine et cancers du sein. Prescrire 2012;32:910. [Ref.ID 94198]
15. Cita con resumen
Obreli-Neto PR, Nobili A, de Oliveira Baldoni A, Guidoni CM, de Lyra Jr DP, Pilger D, Duzanski J, Tettamanti M, Cruciol-Souza JM, Gaeti WP, Cuman RKN. Adverse drug reactions caused by drug-drug interactions in elderly outpatients: a prospective cohort study. Eur J Clin Pharmacol 2012;68:1667-76. [Ref.ID 94168]
16.
Skalli S, Bencheikh RS. Safety monitoring of herb-drug interactions: a component of pharmacovigilance. Drug Saf 2012;35:785-91. [Ref.ID 93810]
17.Enlace a cita original
Tsai HH, Lin HW, Pickard SA, Tsai HY, Mahady GB. Evaluation of documented drug interactions and contraindications associated with herbs and dietary supplements: a systematic literature review. International Journal of Clinical Practice 2012;66:1056-78. [Ref.ID 93669]
18. Cita con resumen
Anónimo. Transport d'anions ou de cations organiques et interactions. Prescrire 2012;32:676-7. [Ref.ID 93662]
19. Cita con resumen
Tsadok MA, Jackevicius CA, Essebag V, Eisenberg MJ, Rahme E, Humphries KH, Tu JV, Behlouli H, Pilote L. Rhythm versus rate control therapy and subsequent stroke or transient ischemic attack in patients with atrial fibrillation. Circulation 2012;126:2680-7. [Ref.ID 93552]
20. Cita con resumen
Warlé-van Herwaarden MF, Kramers C, Sturkenboom MC, van den Bemt PMLA. Targeting outpatient drug safety: recommendations of the Dutch HARM-Wrestling Task Force. Drug Saf 2012;35:245-59. [Ref.ID 92433]
Seleccionar todas
 
 1 a 20 de 345 siguiente >>